These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31645303)

  • 1. [Key points of the announcement for metastatic prostate cancer].
    Bastié JP; Gamé X; Roumiguié M
    Prog Urol; 2019 Nov; 29(15):908-911. PubMed ID: 31645303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer diagnosis announcement: an act to seal the pact of trust between doctors and patients].
    Reich M; Vennin P; Belkacémi Y
    Bull Cancer; 2008 Sep; 95(9):841-7. PubMed ID: 18829417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The announcement of a diagnosis of metastasis: psychological difficulties for the patients].
    Bouregba A; Dallaserra M; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S213-8. PubMed ID: 19070794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The announcement of the diagnosis of cancer: point of view of the general practitioner].
    Ferraton-Rollin M; Magné N; Gonthier R; Merrouche Y; Bois C
    Bull Cancer; 2013 Oct; 100(10):955-62. PubMed ID: 24095773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of prostate-specific antigen with the progression and metastasis of human prostate cancer].
    Zhang SJ; Sun ZY
    Zhonghua Nan Ke Xue; 2018 May; 24(5):457-461. PubMed ID: 30171764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standards, options and recommendations for the management of prostate cancer: therapeutic decision criteria].
    Chatelard PP;
    Bull Cancer; 2002 Jun; 89(6):619-34. PubMed ID: 12135863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis.
    Ciezki JP; Reddy CA; Kupelian PA; Klein EA
    Urology; 2012 Aug; 80(2):367-72. PubMed ID: 22857756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation in the national experiment of cancer diagnosis disclosure in neuro-oncology: implications and the perception of the health care team].
    Tivoli B; Sanchez B; Tardieu S; Metellus P; Sambuc R; Chinot O
    Bull Cancer; 2005 Apr; 92(4):373-80. PubMed ID: 15888394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia diagnostic announcement in a French psychiatric unit].
    Rocamora JF; Benadhira R; Saba G; Stamatadis L; Kalalaou K; Dumortier G; Plaze M; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2005; 31(4 Pt 1):449-55. PubMed ID: 16389712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a favorable subset of patients with prostate cancer who develop oligometastases?
    Singh D; Yi WS; Brasacchio RA; Muhs AG; Smudzin T; Williams JP; Messing E; Okunieff P
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):3-10. PubMed ID: 14697414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Which truth for patients and their family].
    Bréchot JM
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S131-6. PubMed ID: 18235406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
    Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populations.
    Sartor O; Flood E; Beusterien K; Park J; Webb I; MacLean D; Wong BJ; Mark Lin H
    Clin Genitourin Cancer; 2015 Apr; 13(2):101-12. PubMed ID: 25262852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of progression to metastatic prostate cancer in Australia.
    Luo Q; Yu XQ; Smith DP; O'Connell DL
    Cancer Epidemiol; 2015 Aug; 39(4):617-22. PubMed ID: 25983117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
    Heidenreich A; Pfister D; Porres D
    J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.